|
|
|
|
JUPITER tops the news in 2008
Submit a Comment Print Email See Related Articles Cardiology Todays Editorial Board scanned headlines appearing in 2008 and chose the 10 most important stories appearing in our pages last year, with the JUPITER trial topping the list.We...
|
|
|
Pfizer Gets US Patent Office Nod For Reissue Application For Lipitor Enantiomer Patent - Update
Drug maker Pfizer Inc.(PFE: News ), Tuesday said its reissue application to correct technical defects in the '995 enantiomer patent for atorvastatin calcium has been accepted by the U.S. Patent & Trademark Office. The patent...
|
|
|
Gene Therapy - Studies from W.G. Chen and colleagues yield new information about gene therapy
'Chen W, Pendyala S, Natarajan V, Garcia JG, Jacobson JR.Endothelial cell barrier protection by simvastatin: GTPase regulation and NADPH oxidase inhibition,' scientists in the United States report. 'Am J Physiol Lung Cell Mol...
|
|
|
India's Transgene Receives Nod For Cholesterol-lowering Drugs
(AsiaPulse via COMTEX) -- TGBXF | Quote | Chart | News | PowerRating -- Biotechnology firm Transgene Biotek (BSE:526139) on Friday said it had received a licence from the Drug Control Department, Hyderabad, for manufacturing cholesterol...
|
|
|
Transgene Biotek receives license from Drug Control Department
Transgene Biotek Ltd has announced that the Company have been granted the manufacturing license by the Drug Control Department, Hyderabad dated December 30, 2008 vide their letter dated December 31, 2008 for the following products: Orlistat...
|
|
|
Transgene receives nod for cholesterol-lowering drugs
(Asia Pulse Data Source via COMTEX) -- TGBXF | Quote | Chart | News | PowerRating -- Biotechnology firm Transgene Biotek today said it has received licence from the Drug Control Department, Hyderabad, for manufacturing cholesterol-lowering...
|
|
|
Insurance companies urging switch to generics
Source: Drug Topics E-News Email|Print| Del.icio.us Digg Reddit Facebook |Save|License Health insurers have long promoted switching from brand-name medicines to cheaper generics, but now more of them are going further, urging people to take...
|
|
|
Insurance companies urging switch to generics
Source: Drug Topics E-News Email|Print| Del.icio.us Digg Reddit Facebook |Save|License Health insurers have long promoted switching from brand-name medicines to cheaper generics, but now more of them are going further, urging people to take...
|
|
|
Transgene Biotek gets licence
Hyderabad, Jan.2 Transgene Biotek Ltd has received license to manufacture four drugs used in lowering blood cholesterol from the Drug Control Department, Government of Andhra Pradesh. The drugs are Orlistat (also used in the treatment...
|
|
|
Transgene to manufacture four new drugs
Transgene Biotek, an Indian biotech company has been granted a manufacturing license by the Drug Control Department, India.The company can now manufacture the following products; Orlistat, Lovastatin, Simvastatin and Pravastatin.
|
|
|
Dubious Drugs, Tainted Foods Top 2008's Health Stories
WEDNESDAY, Dec.31 (HealthDay News) -- Doubts over the safety of diabetes and heart treatments, disappointing results for vitamins as cancer fighters, and the withdrawal of over-the-counter cold medicines for kids were some of 2008's top...
|
|
|
Dubious Drugs, Tainted Foods Top 2008's Health Stories
WEDNESDAY, Dec.31 (HealthDay News) -- Doubts over the safety of diabetes and heart treatments, disappointing results for vitamins as cancer fighters, and the withdrawal of over-the-counter cold medicines for kids were some of 2008's top...
|
|
|
TopAbstracts in Vascular Disorders 12/25/2008
TopAbstracts in Vascular Disorders are the abstracts most highly rated/most read by nearly 300,000 physicians who received a Doctor's Guide newsletter or visited a website Powered by Doctor's Guide in the past 14 days.Over 2000 peer...
|
|
|
Heart Disease - Research on heart disease reported by scientists at Brigham and Women's Hospital
Learn more about a six-week, no-risk free trial of Heart Disease Weekly We're a pay-per-view site for premium content.If you'd like to purchase this article, it's only $3.00. Heart Disease Research on heart disease reported by...
|
|
|
The Unholy Nexus
A prominent national daily last week reported on the front page how a leading Indian pharmaceutical company is openly enticing the physicians to create more prescriptions for its pharmaceutical products.The brochure circulated by the...
|
|
|
Top Medical Stories of 2008 Challenged 'Lower Is Better' Mantra
When it comes to LDLs and glycosylated hemoglobin, the philosophy of lower is better was dealt evidence-based blows this year with a series of surprising findings.In this year-end review, the editors of MedPage Today present their picks...
|
|
|
- Over-the-counter statins aren't available in U.S
Statins are available only by prescription in the U.S.-- in contrast to the United Kingdom, where in 2004 a low dose (10 milligrams) of simvastatin, sold as Zocor Heart Pro by Merck & Co., was approved for sale without a...
|
|
|
IABCA1/I variant influences degree of LDL cholesterol lowering
variant influences degree of LDL cholesterol lowering Professional News Consumer News Archive News MedWire Interviews considers the challenges and choices faced by clinicians when treating older women with breast cancer.PubMed Or try...
|
|
|
Surprising HIV 'Cure' Was Best-Read MedPage Today Report in 2008
The unlikely 'cure' of a single HIV-infected patient by a bone marrow transplant was the most read story on MedPage Today of the year.The news of a potential cure for HIV first surfaced last February at the Conference on Retroviruses and...
|
|
|
Over-the-counter statins aren't available in U.S
Statins are available only by prescription in the U.S.-- in contrast to the United Kingdom, where in 2004 a low dose (10 milligrams) of simvastatin, sold as Zocor Heart Pro by Merck & Co., was approved for sale without a...
|
|
|
A Practical Approach: Depression
Peter Harris, who has his prescriptions regularly dispensed at the Update Pharmacy, has asked at the medicines counter for St Johns wort tablets and has been referred to pharmacist David Spencer.David asks him why he wants them. For...
|
|
|
Cholesterol drug sales resume their decline
TRENTON Sales of two controversial cholesterol drugs sold by Schering-Plough Corp.and Merck & Co. dropped significantly in November, after their year-long slide appeared to stop the previous month. The figures were released...
|
|
|
Vytorin Debate Reignited
A spate of recent studies has renewed questions about the safety and efficacy of Merck's lipid-lowering drug Vytorin (ezetimibe/simvastatin).The studies have clinicians debating whether Vytorin actually succeeds at what it has been touted...
|
|
|
Further evidence for statin pleiotropy
Circulation 2008; Advance online publication MedWire News: Researchers report further evidence to support beneficial pleiotropic effects of high-dose statins on endothelial function and Rho-associated coiled-coil containing protein kinase ...
|
|
|
Gene Mutations Linked to Statin Resistance
Scientists at have identified genetic mutations that may help explain why some people don't respond very well to statins, drugs that fight high cholesterol and prevent coronary artery disease.The findings, published in Circulation:...
|
